04/16/2024
4:27 PM | Aligos Therapeutics (Filer)
| Form PRE 14A | |
03/12/2024
3:51 PM | Aligos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2024
3:15 PM | Aligos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
4:44 PM | Aligos Therapeutics (Issuer)
McClure Matthew W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:41 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:42 PM | Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:42 PM | Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/28/2024
4:28 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
4:29 PM | Aligos Therapeutics (Issuer)
Martell Bridget A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:29 PM | Aligos Therapeutics (Issuer)
Nuechterlein Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:30 PM | Aligos Therapeutics (Issuer)
Nielsen Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:31 PM | Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:32 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:32 PM | Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:33 PM | Aligos Therapeutics (Issuer)
McClure Matthew W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:34 PM | Aligos Therapeutics (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:35 PM | Aligos Therapeutics (Issuer)
Hirth Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:23 PM | Aligos Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
02/08/2024
4:44 PM | Aligos Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
01/30/2024
6:04 AM | Aligos Therapeutics (Subject)
| Form SC TO-I | |
01/25/2024
5:06 AM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
5:12 AM | Aligos Therapeutics (Subject)
| Form SC TO-C | |
11/28/2023
3:01 PM | Aligos Therapeutics (Filer)
| Form 424B3 | |
11/27/2023
11:15 PM | Aligos Therapeutics (Filer)
| Form EFFECT | |
11/17/2023
3:38 PM | Aligos Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/15/2023
3:01 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
4:14 PM | Aligos Therapeutics (Issuer)
ROCHE FINANCE LTD (Reporting)
ROCHE HOLDING LTD (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/07/2023
4:16 PM | Aligos Therapeutics (Subject)
ROCHE FINANCE LTD (Filed by)
| Form SC 13G/A | |
11/07/2023
11:03 AM | Aligos Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/06/2023
3:05 PM | Aligos Therapeutics (Subject)
BLATT LAWRENCE (Filed by)
| Form SC 13D | |
11/02/2023
3:23 PM | Aligos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023
3:13 PM | Aligos Therapeutics (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
3:14 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
3:15 PM | Aligos Therapeutics (Issuer)
Nuechterlein Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2023
4:05 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
7:45 AM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
3:05 PM | Aligos Therapeutics (Issuer)
BLATT LAWRENCE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:06 PM | Aligos Therapeutics (Issuer)
Symons Julian A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:07 PM | Aligos Therapeutics (Issuer)
Quan Lucinda Y. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:07 PM | Aligos Therapeutics (Issuer)
Calhoun Lesley Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:08 PM | Aligos Therapeutics (Issuer)
McClure Matthew W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Apple-like Innovator is Revolutionizing Healthcare (Ad) AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing.
Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry |
09/07/2023
3:01 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
3:52 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
8:06 PM | Aligos Therapeutics (Issuer)
Martell Bridget A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
6:23 PM | Aligos Therapeutics (Issuer)
Nielsen Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
3:10 PM | Aligos Therapeutics (Issuer)
Nuechterlein Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
3:11 PM | Aligos Therapeutics (Issuer)
Scopa James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
3:13 PM | Aligos Therapeutics (Issuer)
Hirth Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
3:05 PM | Aligos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
3:47 PM | Aligos Therapeutics (Filer)
| Form DEF 14A | |
